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Introduction Engineered tissue grafts, which 
mimic the spatial variations of cell density and 
extracellular matrix present in native tissues, 
could facilitate more efficient tissue regeneration 
and integration. We previously demonstrated 
that cells could be uniformly seeded throughout 
a 3D scaffold having a random pore architecture 
using a perfusion bioreactor2. In this work, we 
aimed to generate 3D constructs with defined 
cell distributions based on rapid prototyped 
scaffolds manufactured with a controlled 
gradient in porosity. Computational models were 
developed to assess the influence of fluid flow, 
associated with pore architecture and perfusion 
regime, on the resulting cell distribution. 
Materials and Methods Two scaffold 
architectures based on poly(D,L-lactide) were 
prepared by stereolithography2: Isotropic in 
porosity and pore size (“ISO”; 62% porous) or 
Radial Gradient in pore size and porosity (“RG”; 
center: 85% porous; periphery: 35% porous). 
Steady state flow within scaffolds was simulated 
using Fluent 6.33. Chondrocytes were perfusion 
seeded throughout the scaffolds as previously 
described1. Following cell seeding, constructs 
were stained with SYTO-13, images acquired by 
confocal microscopy and thresholded to obtain 
black-and-white pictures. 
Results CFD simulations indicated that, as 
compared to the ISO scaffold, the architecture of 
RG induced radial velocity and shear gradients, 
with higher velocities and shear stresses towards 
the centre of the scaffold (Fig.1C&D). Cells 
seeded within ISO scaffolds were 
homogeneously distributed throughout the entire 
scaffold, whereas cells within RG scaffolds were 
seeded at a higher density towards the center of 
the scaffold where the porosity was higher and 
the shear stresses higher (Fig.1E&F). 
Discussion and Conclusions We have shown 
that perfusion cell seeding of rapid prototyped 
scaffolds having defined pore architectures can  
 
 
 
Fig. 1. Isotropic and Radial Gradient scaffolds. 
(A,B) μCT 2D reconstructions; (C,D) shear 
stress profiles; (E,F) confocal images. 
 
generate 3D constructs with specific cell 
distributions. In these scaffolds, higher cell 
densities were observed in pores exposed to 
higher fluid velocities and shear stresses. The 
developed model system establishes a foundation 
to obtain new insights into the relation among 
scaffold architecture, mechanical stimuli and 
biological response, paving the way to 
engineering complex 3D constructs with defined 
structural organization.  
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